tiprankstipranks
Trending News
More News >
BioLineRX Ltd. (IL:BLRX)
:BLRX
Israel Market

Bioline Rx (BLRX) Financial Statements

Compare
2 Followers

Bioline Rx Financial Overview

Bioline Rx's market cap is currently 41.77M. The company's EPS TTM is 0; its P/E ratio is -1.85; Bioline Rx is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is -0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 28.94M$ 4.80M$ 0.00$ 0.00$ 0.00
Gross Profit$ 19.68M$ 1.11M$ 0.00$ 0.00$ 0.00
Operating Income$ -20.41M$ -49.69M$ -29.16M$ -24.78M$ -22.93M
EBITDA$ 3.92M$ -57.09M$ -28.50M$ -24.07M$ -21.99M
Net Income$ -9.22M$ -60.61M$ -20.75M$ -28.14M$ -30.93M
Balance Sheet
Cash & Short-Term Investments$ 19.56M$ 42.99M$ 51.08M$ 57.13M$ 22.59M
Total Assets$ 38.91M$ 63.92M$ 76.38M$ 81.39M$ 47.29M
Total Debt$ 15.04M$ 11.59M$ 12.32M$ 4.65M$ 7.68M
Net Debt$ 4.60M$ 7.34M$ 1.74M$ -8.34M$ -9.15M
Total Liabilities$ 25.45M$ 50.70M$ 25.54M$ 13.30M$ 25.26M
Stockholders' Equity$ 13.46M$ 13.22M$ 50.84M$ 68.09M$ 22.03M
Cash Flow
Free Cash Flow$ -43.93M$ -22.91M$ -26.56M$ -23.67M$ -23.21M
Operating Cash Flow$ -43.87M$ -22.61M$ -26.24M$ -23.57M$ -23.21M
Investing Cash Flow$ 29.37M$ 1.44M$ 4.01M$ -38.22M$ 16.67M
Financing Cash Flow$ 20.66M$ 15.06M$ 20.44M$ 57.75M$ 17.87M
Currency in USD

Bioline Rx Earnings and Revenue History

Bioline Rx Debt to Assets

Bioline Rx Cash Flow

Bioline Rx Forecast EPS vs Actual EPS